Q: Is kennel cough a risk to humans?

Yes, Bordetella bronchiseptica is a zoonotic pathogen, and it can cause respiratory illness in humans, particularly those who are immunocompromised.

# Bordetella Kennel Cough Vaccine: Oral vs Nasal vs Injectable Efficacy ## Key Takeaways - Intranasal and oral *Bordetella bronchiseptica* vaccines induce rapid local mucosal immunity (IgA) at the respiratory tract's portal of entry, offering faster protection than injectable vaccines which primarily stimulate systemic immunity (IgG). - The intranasal vaccine is demonstrated to provide protection within 72 hours of administration, making it the preferred choice for dogs requiring immediate protection before high-risk events like boarding or grooming. - Oral vaccination has shown efficacy for one year against *Bordetella bronchiseptica* challenge and offers a non-invasive, needle-free alternative, reducing stress for some canine patients. - Injectable *Bordetella* vaccines, typically inactivated, are easier to administer in fractious dogs and can be combined with other core vaccines but are slower to induce immunity and less effective at stimulating local mucosal defense. - *Bordetella bronchiseptica* is a zoonotic pathogen, capable of causing respiratory illness in immunocompromised humans, underscoring the public health relevance of canine vaccination. - While vaccination significantly reduces the severity and duration of kennel cough, it does not guarantee complete prevention; vaccinated dogs may still contract the disease but typically experience milder clinical signs. --- ## A Direct Answer for Pet Owners When a client asks, "Which kennel cough vaccine is best, the shot, the nose drops, or the oral liquid?", the evidence-based answer is nuanced but clear. **The intranasal (nasal) and oral (given by mouth) vaccines provide the fastest and most robust local immunity at the site of infection, while the injectable vaccine primarily provides systemic immunity and is generally slower to induce protection.** For most dogs needing rapid protection before boarding, grooming, or a visit to a [dog park](/knowledge/veterinary-medicine/clinical-methods/dog-park), the intranasal or oral vaccines are preferred due to their rapid onset of immunity. The injectable form remains a viable option, particularly for dogs that are difficult to restrain or those with a history of adverse reactions to intranasal vaccines. This article provides a definitive, source-grounded comparison of the three routes of administration for the *[Bordetella bronchiseptica](/knowledge/bacteria/pet-bacteria/bordetella-bronchiseptica)* component of the kennel cough vaccine. We will examine the scientific evidence, practical clinical considerations, and what you should discuss with your veterinarian. **Owner-Facing Triage Summary:** - **If your [dog](/knowledge/veterinary-medicine/clinical-methods/dog) needs protection within 72 hours:** The intranasal vaccine has been shown to protect dogs from experimental challenge within 72 hours of administration [1]. - **If your dog is going to a high-risk environment (kennel, shelter, daycare):** The intranasal vaccine is a strong choice, with studies showing efficacy in shelter settings [2]. - **If you want a full year of protection with a non-invasive method:** The oral vaccine has demonstrated one year of immunity against *Bordetella bronchiseptica* challenge [3, 4]. - **If your dog is aggressive or difficult to handle near the face:** The injectable vaccine may be easier to administer, though it offers a different profile of immunity. - **Always discuss with your veterinarian:** The choice depends on your dog's lifestyle, health status, and the specific products available in your region. --- ## At a Glance: Comparing Vaccination Routes The following table summarizes the key differences between the three routes of *Bordetella bronchiseptica* vaccination. This is a clinical guide, not a substitute for professional advice. | Feature | Intranasal (IN) | Oral | Injectable | | :--- | :--- | :--- | :--- | | **Primary Immune Response** | Local mucosal immunity (IgA) in the respiratory tract; rapid systemic response | Local mucosal immunity in the oral/pharyngeal and respiratory tract; systemic response | Systemic immunity (IgG); less local mucosal response | | **Onset of Immunity** | **Rapid.** Protection demonstrated within 72 hours [1]. | **Moderate.** Provides one year of immunity, but onset is not as rapid as IN. | **Slower.** Typically requires two doses given 2-4 weeks apart for primary series; onset is delayed. | | **Duration of Immunity** | Variable, often labeled annually or every 6 months depending on product and risk. | **One year** demonstrated in clinical trials [3, 4]. | Variable, often labeled annually. | | **Route of Administration** | Instilled into the nostril(s). | Given orally, often on the cheek mucosa or swallowed. | Subcutaneous or intramuscular injection. | | **Key Advantages** | Fastest onset of local immunity; good for last-minute boarding [1]. | Non-invasive; no needle; less stressful for some dogs; provides one year of immunity [3, 4]. | Easiest to administer in fractious dogs; can be combined with other injectable vaccines (e.g., DA2PP). | | **Key Disadvantages** | Requires handling the dog's head; can cause transient sneezing, coughing, or nasal discharge. | Requires the dog to cooperate with oral administration; may not be suitable for all dogs. | Slower onset; does not stimulate local mucosal immunity as effectively as IN or oral routes; may be less effective at preventing infection at the portal of entry. | | **Evidence for Efficacy** | Strong. Multiple studies support efficacy in challenge models and shelter settings [1, 2, 5, 6]. | Strong. Recent studies confirm one-year duration of immunity [3, 4]. | Moderate. Used widely, but fewer comparative studies against the intranasal route in peer-reviewed literature. | --- ## Understanding Bordetella and Kennel Cough ### The Pathogen and the Disease Kennel cough, or canine infectious tracheobronchitis, is a highly contagious respiratory disease complex. While several viruses and bacteria can be involved, *Bordetella bronchiseptica* is a primary bacterial agent [7, 8]. This bacterium attaches to the cilia of the respiratory epithelium, impairing their function and leading to the characteristic dry, hacking cough. The disease is spread through aerosolized respiratory droplets and direct contact with contaminated surfaces. The clinical signs can range from a mild, self-limiting cough to severe pneumonia, particularly in young puppies, immunocompromised dogs, or those with underlying respiratory conditions. The bacterium is not only a concern for dogs; it is a zoonotic pathogen, meaning it can be transmitted to humans, especially those who are immunocompromised [7]. A case report highlighted an infant with persistent *B. bronchiseptica* pneumonia, and genetic comparison showed that clinical isolates were related to kennel cough vaccine strains [7]. This underscores the importance of vaccination not only for the dog's health but also for public health considerations for vulnerable owners [9]. ### Why Vaccination Route Matters The respiratory tract is the primary entry point for *Bordetella bronchiseptica*. Therefore, the most effective immunity is one that acts at the mucosal surface. This is the fundamental principle behind the intranasal and oral vaccines. They are designed to stimulate a local immune response, primarily secretory Immunoglobulin A (IgA), which acts as a first line of defense at the site of infection. In contrast, the injectable vaccine stimulates a strong systemic immune response, primarily Immunoglobulin G (IgG), which circulates in the blood. While this systemic response can help prevent severe disease, it does not always prevent the initial colonization of the respiratory tract by the bacteria. This is why the intranasal and oral routes are often favored in high-risk situations. --- ## The Intranasal Vaccine: Rapid Local Protection The intranasal (IN) vaccine is the most extensively studied route for *Bordetella bronchiseptica* vaccination. It contains a modified-live (attenuated) strain of the bacterium, which is administered directly into the nasal passages. ### Evidence for Intranasal Efficacy The scientific literature strongly supports the efficacy of the intranasal vaccine. - **Rapid Onset of Immunity:** A pivotal study by Gore et al. (2005) demonstrated that the intranasal kennel cough vaccine protected dogs from experimental *Bordetella bronchiseptica* challenge within 72 hours of vaccination [1]. This is a critical advantage for dogs that need to be boarded or groomed on short notice. - **Reduction in Clinical Signs and Viral Shedding:** An early study by Kontor et al. (1981) evaluated a combined intranasal vaccine for canine parainfluenza and *B. bronchiseptica*. The study found that the vaccine was effective in reducing the clinical signs of tracheobronchitis and also reduced viral shedding [5]. This is important for controlling the spread of the disease in group settings. - **Long-Standing Evidence:** The efficacy of intranasal vaccination has been recognized for decades. A study by Shade and Goodnow (1979) demonstrated that intranasal immunization with a modified-live *B. bronchiseptica* vaccine protected dogs against induced tracheobronchitis [6]. This early work laid the foundation for the modern intranasal vaccines. - **Real-World Shelter Efficacy:** A placebo-controlled trial by Edinboro et al. (2004) evaluated two intranasal vaccines in dogs entering a humane shelter. The study found that the intranasal vaccines were effective in preventing tracheobronchitis in this high-risk, real-world setting [2]. This is particularly relevant for shelter medicine and rescue operations. - **Historical Context:** Even earlier trials, such as the one by Glickman and Appel (1981), confirmed the efficacy of intranasal vaccines for canine infectious tracheobronchitis [10]. ### Clinical Considerations for Intranasal Vaccines - **Advantages:** The primary advantage is the rapid onset of local immunity, which is ideal for dogs with sudden exposure risk [1]. It also provides excellent mucosal immunity, which is the most natural route of defense. - **Disadvantages:** The main drawbacks include the need to restrain the dog's head for administration. Some dogs may object to the nasal drops. Transient sneezing, coughing, or a mild nasal discharge are common and harmless side effects that can occur for a few days after vaccination. - **Behavioral Impact on Working Dogs:** A study by Collins et al. (2022) investigated the effects of intranasal and oral *Bordetella* vaccination on the behavioral and olfactory capabilities of detection dogs. This study is crucial because it addresses a specific concern for working dog handlers. The findings suggest that vaccination route can have an impact, and it is a key consideration for professionals managing detection dogs [11]. --- ## The Oral Vaccine: A Non-Invasive, Long-Duration Option The oral vaccine is a more recent addition to the kennel cough vaccine arsenal. It is administered by mouth, typically by placing the liquid in the dog's cheek pouch, where it is absorbed across the oral mucosa. It also contains a modified-live *Bordetella bronchiseptica* strain. ### Evidence for Oral Vaccine Efficacy The oral vaccine has been shown to provide a full year of immunity, making it a highly convenient option. - **One-Year Duration of Immunity:** A study by Hainer et al. (2021) demonstrated that oral vaccination of dogs with a monovalent live-avirulent vaccine conferred one year of immunity against *Bordetella bronchiseptica* challenge [4]. This confirms the vaccine's ability to provide long-lasting protection. - **Combination Vaccine Efficacy:** A more recent study by Wiechert-Brown et al. (2025) evaluated a combination *Bordetella bronchiseptica* and canine parainfluenza oral vaccine. The study confirmed that this combination vaccine also provides one year of duration of immunity [3]. This is valuable for owners who want comprehensive protection against the major causes of kennel cough with a single, non-invasive dose. - **Public Health Considerations:** The oral vaccine is part of the broader conversation about protecting vulnerable owners. As noted by Moore et al. (2021), vaccination against *Bordetella* is important for reducing the risk of zoonotic transmission to immunocompromised individuals [9]. ### Clinical Considerations for Oral Vaccines - **Advantages:** The oral vaccine is non-invasive and needle-free, which can reduce stress for many dogs. It provides a full year of immunity, which is convenient for annual vaccination protocols [3, 4]. It is also an excellent choice for dogs that are difficult to handle around the head. - **Disadvantages:** The primary disadvantage is that it may not provide the same rapid onset of immunity as the intranasal vaccine. While it is effective, it is not typically marketed for the 72-hour protection window that the intranasal vaccine offers. Administration requires the dog to be calm enough to accept the liquid in its mouth. - **Working Dog Considerations:** As with the intranasal vaccine, the oral vaccine's impact on behavior and olfaction in detection dogs has been studied. The research by Collins et al. (2022) directly compared these two routes, providing essential data for handlers [11]. --- ## The Injectable Vaccine: Systemic Immunity and Practicality The injectable *Bordetella* vaccine is typically a killed (inactivated) or subunit vaccine. It is administered subcutaneously or intramuscularly, often in combination with other core vaccines like distemper, adenovirus, and parainfluenza (DA2PP). ### Evidence and Clinical Use of Injectable Vaccines The injectable vaccine is widely used, but its efficacy profile differs from the mucosal vaccines. - **Mechanism of Action:** It stimulates a strong systemic immune response (IgG). This helps to prevent severe disease, pneumonia, and systemic spread of the bacteria. However, it is less effective at stimulating the local mucosal IgA response that is the first line of defense in the respiratory tract. - **Onset of Immunity:** The injectable vaccine typically requires a primary series of two doses, given 2 to 4 weeks apart, to establish immunity. This makes it unsuitable for last-minute protection. - **Clinical Use:** It is a practical choice for dogs that are aggressive or difficult to restrain for intranasal or oral administration. It is also convenient because it can be combined with other routine vaccinations, reducing the number of visits. However, it is generally considered less effective at preventing the initial infection and shedding of *B. bronchiseptica* compared to the intranasal route. ### Weighing the Options The choice between injectable and mucosal vaccines is a classic example of the trade-off between systemic and local immunity. For a dog that is regularly exposed to high-risk environments, the intranasal or oral vaccine is generally preferred. The injectable vaccine may be chosen for its ease of administration, but veterinarians should discuss the differences in protection with the owner. --- ## Comparative Efficacy: What the Science Says When comparing the three routes, the scientific literature provides a clear hierarchy for specific outcomes. 1. **Fastest Protection:** The intranasal vaccine wins decisively. The study by Gore et al. (2005) is the gold standard, demonstrating protection within 72 hours [1]. No comparable rapid-onset data exists for the oral or injectable vaccines in the provided sources. 2. **Duration of Immunity:** Both the intranasal and oral vaccines can provide one year of immunity. The oral vaccine has explicit, recent studies confirming this [3, 4]. The intranasal vaccine has also been shown to be effective, though its labeled duration may vary by product. 3. **Mucosal vs. Systemic Protection:** The intranasal and oral vaccines are superior for stimulating local immunity at the portal of entry. The injectable vaccine is superior for generating high levels of systemic antibodies. For a pathogen like *B. bronchiseptica* that colonizes the respiratory mucosa, local immunity is more effective at preventing infection and shedding. 4. **Shelter and High-Risk Settings:** The intranasal vaccine has the strongest evidence base for use in shelters, where the risk of disease is high and rapid protection is needed [2]. The oral vaccine is also a good option, but the shelter-specific data is more robust for the intranasal route. --- ## Anatomy, Physiology, and How the Vaccines Work To understand why the route of administration matters, it is helpful to understand the anatomy of the immune system in the respiratory tract. - **Mucosal-Associated Lymphoid Tissue (MALT):** The respiratory tract is lined with MALT, which contains specialized immune cells that sample antigens from the air and mucosal surfaces. When a vaccine is given intranasally or orally, it is taken up by this tissue, leading to the production of secretory IgA antibodies. These antibodies are secreted onto the mucosal surface, where they can neutralize the bacteria before it attaches to the cells. - **Systemic Immune System:** The injectable vaccine is delivered into the muscle or subcutaneous tissue, where it is picked up by antigen-presenting cells and transported to lymph nodes. This stimulates the production of IgG antibodies in the blood. These antibodies can neutralize the bacteria if it enters the bloodstream, but they are less effective at the mucosal surface. The intranasal and oral vaccines essentially "train" the immune system at the exact location where the infection occurs. The injectable vaccine trains the "bodyguard" cells in the blood but leaves the "front door" less well-guarded. --- ## Risk Factors and When to Vaccinate Vaccination against *Bordetella bronchiseptica* is considered a core recommendation for dogs at risk of exposure. This includes: - Dogs that are boarded, groomed, or attend daycare. - Dogs that participate in dog shows, agility, or other group activities. - Dogs that are frequently walked in areas with high dog traffic (e.g., dog parks). - Dogs entering a shelter or rescue environment [2]. The decision to vaccinate and the choice of route should be based on a lifestyle assessment by your veterinarian. For a dog that is a solitary pet with minimal contact with other dogs, the risk may be low. However, for most social dogs, vaccination is strongly recommended. --- ## Veterinary Examination and Diagnostics If a dog develops a cough, a veterinarian will perform a thorough physical examination. They will listen to the lungs and trachea and assess the dog's overall health. In many cases, the characteristic "goose-honk" cough is sufficient for a presumptive diagnosis of kennel cough. However, diagnostics may be recommended to rule out other causes, such as: - Canine influenza virus - [Canine distemper virus](/knowledge/viruses/pet-viruses/canine-distemper-virus) - Foreign bodies in the airway - Collapsing trachea - Heart disease - Pneumonia Diagnostic tests may include chest X-rays, blood work, and tracheal washes to identify the specific pathogen. It is important to note that a dog can be infected with *Bordetella bronchiseptica* even if it has been vaccinated, as the vaccine does not provide 100% sterilizing immunity. However, vaccinated dogs typically experience much milder clinical signs and recover faster. --- ## Evidence-Based Management and Prevention ### Vaccination is the Cornerstone The most effective way to prevent kennel cough is through vaccination. The choice of vaccine should be tailored to the individual dog's risk and lifestyle. - **For rapid protection:** Use the intranasal vaccine, which is effective within 72 hours [1]. - **For annual, non-invasive protection:** Use the oral vaccine, which provides one year of immunity [3, 4]. - **For ease of administration in difficult dogs:** The injectable vaccine may be used, but its slower onset and different immune profile should be considered. ### Management of Infected Dogs If a dog does develop kennel cough, treatment is primarily supportive. This includes rest, good nutrition, and avoiding irritants like smoke or dust. Cough suppressants may be prescribed by a veterinarian to provide comfort, but they should be used with caution. Antibiotics may be indicated if a secondary bacterial infection is suspected, but they are not always necessary for uncomplicated cases. ### Unsafe Home Remedies It is crucial to warn owners against unsafe home remedies. Do not administer human cough medications to dogs without veterinary approval, as many are toxic. Do not use essential oils or other homeopathic remedies that have not been proven safe and effective. Always consult a veterinarian before giving any medication. --- ## Prevention and Prognosis The prognosis for kennel cough is generally excellent. Most dogs recover within one to three weeks with supportive care. However, the disease can be severe or even fatal in puppies, senior dogs, and immunocompromised animals. In these patients, pneumonia can develop, requiring intensive veterinary care. Prevention through vaccination is the best strategy. By choosing the right vaccine and following a regular booster schedule, owners can significantly reduce the risk of their dog contracting this highly contagious disease. --- ## Limitations and When to Contact a Veterinarian This article provides a general overview of the efficacy of different *Bordetella* vaccines. It is essential to understand the limitations of this information. - **Breed-Level Information:** This article does not and cannot predict how a specific breed will respond to a vaccine. Individual reactions can vary. - **Product Variation:** The specific products available in your region (United States, Canada, Europe, Australia) may have different labels, indications, and durations of immunity. Always follow the manufacturer's instructions and your veterinarian's advice. - **Individual Health:** A dog's overall health, age, and immune status can influence vaccine efficacy and safety. **Contact your veterinarian immediately if your dog exhibits any of the following red flags after vaccination or if they develop kennel cough:** - Difficulty breathing or rapid, labored breathing. - Lethargy, weakness, or collapse. - Refusal to eat or drink for more than 24 hours. - A cough that persists for more than two weeks or is getting worse. - Coughing up blood or green/yellow discharge. - Fever. - Swelling of the face or hives (signs of an allergic reaction). --- ## Frequently Asked Questions ### 1. Which kennel cough vaccine works the fastest? The intranasal vaccine provides the fastest protection, with studies showing efficacy within 72 hours of administration [1]. ### 2. How long does the oral Bordetella vaccine last? The oral vaccine has been proven to provide one year of immunity against *Bordetella bronchiseptica* challenge [3, 4]. ### 3. Is the injectable kennel cough vaccine as effective as the intranasal one? The injectable vaccine is effective at preventing severe disease but is generally considered less effective at preventing initial infection at the mucosal surface compared to the intranasal vaccine. ### 4. Can my dog get kennel cough even if it is vaccinated? Yes, vaccinated dogs can still get kennel cough, but they typically experience much milder clinical signs and recover faster than unvaccinated dogs. ### 5. What are the common side effects of the intranasal vaccine? Common side effects are mild and transient, including sneezing, coughing, or a slight nasal discharge for a few days after administration. ### 6. Is the oral vaccine a good option for dogs that hate needles? Yes, the oral vaccine is a non-invasive, needle-free option that provides a full year of immunity and is an excellent choice for reducing stress [3, 4]. ### 7. Is kennel cough a risk to humans? Yes, *Bordetella bronchiseptica* is a zoonotic pathogen, and it can cause respiratory illness in humans, particularly those who are immunocompromised [7, 9]. ### 8. Which vaccine is best for a dog entering a shelter? The intranasal vaccine has strong evidence for efficacy in shelter settings, providing rapid protection in a high-risk environment [2]. --- ## Related Clinical & Scientific Guides * [Dog Allergic Reaction: Comprehensive Veterinary Reference Guide](/knowledge/veterinary-medicine/preventive-care/dog-allergic-reaction) * [Puppy Socialization and Preventive Behavior: Early Training and Handling](/knowledge/veterinary-medicine/preventive-care/puppy-socialization-preventive-behavior) * [Dog Boarding 101: How to Choose the Best Facility for Your Pet](/knowledge/veterinary-medicine/preventive-care/dog-boarding-guide)